Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001795715 | SCV002140065 | pathogenic | not provided | 2024-03-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln115*) in the IFT43 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT43 are known to be pathogenic (PMID: 21378380, 28400947). This variant is present in population databases (rs201794999, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with IFT43-related conditions. ClinVar contains an entry for this variant (Variation ID: 1328283). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005005286 | SCV005633358 | likely pathogenic | Cranioectodermal dysplasia 3; Short-rib thoracic dysplasia 18 with polydactyly; Retinitis pigmentosa 81 | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001795715 | SCV002036373 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001795715 | SCV002038133 | pathogenic | not provided | no assertion criteria provided | clinical testing |